Quintana-Ortega Cristian, Remesal Agustín, Vigara Ana Pérez, Parrón-Pajares Manuel, Bret Montserrat, Alcobendas Rosa, Murias Sara
Paediatric Rheumatology Department, La Paz Children's Hospital, Madrid, Spain.
Paediatric Radiology Department, La Paz Children's Hospital, Madrid, Spain.
Mediterr J Rheumatol. 2022 Dec 31;33(4):459-464. doi: 10.31138/mjr.33.4.459. eCollection 2022 Dec.
Thrombocytopenia is a common hematologic abnormality of childhood-onset systemic lupus erythematosus (cSLE). Although in most cases thrombocytopenia is mild, severe thrombocytopenia with bleeding complications might occur, and is further correlated with disease activity and a worse prognosis. We report two female patients with severe thrombocytopenia as the initial manifestation of cSLE, which were successfully treated by intensive immunosuppression including several high-dose methylprednisolone pulses and IV cyclophosphamide. Both patients were initially diagnosed with idiopathic thrombopenic purpura (ITP) refractory to conventional treatment and complicated with haemorrhagic manifestations. For this matter, patients with ITP should be assessed for the presence of ANA, anti-dsDNA antibodies, and complement levels, since they are at high risk to develop cSLE.
血小板减少是儿童期系统性红斑狼疮(cSLE)常见的血液学异常。虽然在大多数情况下血小板减少较轻,但可能会出现伴有出血并发症的严重血小板减少,且与疾病活动及更差的预后相关。我们报告了两名以严重血小板减少为cSLE初始表现的女性患者,她们通过强化免疫抑制治疗成功治愈,包括多次大剂量甲泼尼龙冲击治疗和静脉注射环磷酰胺。两名患者最初均被诊断为常规治疗无效且伴有出血表现的特发性血小板减少性紫癜(ITP)。鉴于ITP患者有发展为cSLE的高风险,因此应对其进行抗核抗体(ANA)、抗双链DNA抗体及补体水平的评估。